InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,179.16
(
-0.16%
)
US TECH 100
17,524.00
(
-0.50%
)
Dow Jones
38,867.11
(
-0.04%
)
Brent Oil
82.32
(
-0.66%
)
Bitcoin
62,049.99
(
-0.46%
)
Post# of 298
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

TERIA

Send PM Follow Ignore
Followers 2
Posts 34
Boards Moderated 1
Alias Born 07/14/2015

TERIA

Re: None

Tuesday, 04/11/2017 11:15:10 AM

Tuesday, April 11, 2017 11:15:10 AM

Post# of 298
AstraZeneca Head of Neuroscience, Dr Iain Chessell, presents new opportunity to expand efficacy of anti-NGF's to neuropathic pain. Interesting to see what they have in store at the 17th Pain Therapeutics industry summit. insert-text-here
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent AZN News
More AZN News
InvestorsHub NewsWire

FEATURED Element79 Gold Corp Successfully Closes Maverick Springs Option Agreement • May 8, 2024 9:05 AM

Kona Gold Beverages, Inc. Achieves April Revenues Exceeding $586,000 • KGKG • May 8, 2024 8:30 AM

Epazz plans to spin off Galaxy Batteries Inc. • EPAZ • May 8, 2024 7:05 AM

Moon Equity Holdings, Corp. Announces Acquisition of Wikolo, Inc. • MONI • May 7, 2024 9:48 AM

Cannabix Technologies Launches New Compact Breath Logix Workplace Series and Prepares for Delivery to South Africa • BLOZF • May 7, 2024 8:51 AM

NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM

Start posting your company's news
Only $200 per official company press release!